ANTIGEN AND ANTIBODY FOR HEPATITIS C VIRUS (HCV AG/ANTI-HCV) - ANVISA Registration 80020690319

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY FOR HEPATITIS C VIRUS (HCV AG/ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690319 and manufactured by BIO-RAD. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Jun 02, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including DIASORIN ITALIA S.P.A. UK BRANCH, ROCHE DIAGNOSTICS GMBH, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.